{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:05:43Z","timestamp":1762067143415},"reference-count":20,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4442","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1980,4,25]]},"abstract":"<jats:p>Hydralazine, the prototypic drug that induces systemic lupus erythematosus, reacts with thymidine and deoxycytidine. Analysis of a reaction mixture of therapeutic concentrations of hydralazine with labeled thymidine reveals at least four labeled products. At higher concentrations, hydralazine reacts with labeled deoxycytidine to form at least three labeled products. Formation of these products is markedly enhanced by exposure to ultraviolet light. The reaction of hydralazine with thymidine and deoxycytidine may be in part responsible for initiating drug-induced systemic lupus erythematosus.<\/jats:p>","DOI":"10.1126\/science.7367866","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T17:45:58Z","timestamp":1160070358000},"page":"404-406","source":"Crossref","is-referenced-by-count":65,"title":["Hydralazine-Pyrimidine Interactions May Explain Hydralazine-Induced Lupus Erythematosus"],"prefix":"10.1126","volume":"208","author":[{"given":"Lewis M.","family":"Dubroff","sequence":"first","affiliation":[{"name":"Department of Medicine, State University of New York, Syracuse 13210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert J.","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Syracuse 13210"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","first-page":"543","volume":"15","year":"1973","unstructured":"ALARCONSEGOVIA, D, ANTIGENIC SPECIFICITY OF CHLORPROMAZINE-INDUCED ANTINUCLEAR ANTIBODIES, CLINICAL AND EXPERIMENTAL IMMUNOLOGY 15: 543 (1973).","journal-title":"CLINICAL AND EXPERIMENTAL IMMUNOLOGY"},{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-197612010-00003","volume":"12","year":"1976","unstructured":"ALARCONSEGOVIA, D, DRUG-INDUCED ANTINUCLEAR ANTIBODIES AND LUPUS SYNDROMES, DRUGS 12: 69 (1976).","journal-title":"DRUGS"},{"key":"e_1_2_1_3_1","first-page":"664","volume":"44","year":"1969","unstructured":"ALARCONSEGOVIA, D, DRUG-INDUCED LUPUS SYNDROMES, MAYO CLINIC PROCEEDINGS 44: 664 (1969).","journal-title":"MAYO CLINIC PROCEEDINGS"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0002-9343(72)90021-6","volume":"52","year":"1972","unstructured":"BLOMGREN, S.E., PROCAINAMIDE-INDUCED LUPUS-ERYTHEMATOSUS - CLINICAL AND LABORATORY OBSERVATIONS, AMERICAN JOURNAL OF MEDICINE 52: 338 (1972).","journal-title":"AMERICAN JOURNAL OF MEDICINE"},{"key":"e_1_2_1_5_1","first-page":"470","volume":"11","year":"1968","unstructured":"BLOMGREN, S. E., ARTHRITIS AND RHEUMATISM 11: 470 (1968).","journal-title":"ARTHRITIS AND RHEUMATISM"},{"key":"e_1_2_1_6_1","first-page":"31","volume":"12","year":"1968","unstructured":"Brown, D., Methods in Enzymology 12A: 31 (1968).","journal-title":"Methods in Enzymology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0006-291X(66)90345-7","volume":"24","year":"1966","unstructured":"BROWN, D.M., CHEMICAL BASIS OF HYDRAZINE MUTAGENESIS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 24: 967 (1966).","journal-title":"BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS"},{"key":"e_1_2_1_8_1","unstructured":"Dubois E. L. Lupus Erythematosus (1974)."},{"key":"e_1_2_1_9_1","unstructured":"DUBROFF L UNPUBLISHED."},{"key":"e_1_2_1_10_1","first-page":"263","volume":"3","year":"1974","unstructured":"ELDREDGE, N.T., INTERACTION OF LUPUS-INDUCING DRUGS WITH DEOXYRIBONUCLEIC-ACID, CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 3: 263 (1974).","journal-title":"CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-76-3-365","volume":"76","year":"1972","unstructured":"HAHN, B.H., IMMUNE-RESPONSES TO HYDRALAZINE AND NUCLEAR ANTIGENS IN HYDRALAZINE-INDUCED LUPUS-ERYTHEMATOSUS, ANNALS OF INTERNAL MEDICINE 76: 365 (1972).","journal-title":"ANNALS OF INTERNAL MEDICINE"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.1960.03020240045009","volume":"173","year":"1960","unstructured":"HILDRETH, E. A., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 173: 657 (1960).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/jo01056a057","volume":"27","year":"1962","unstructured":"KELLY, R.B., AGARITINE - ISOLATION, DEGRADATION, AND SYNTHESIS, JOURNAL OF ORGANIC CHEMISTRY 27: 3229 (1962).","journal-title":"JOURNAL OF ORGANIC CHEMISTRY"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archinte.1966.03870110012003","volume":"117","year":"1966","unstructured":"LEE, S.L., ACTIVATION OF SYSTEMIC LUPUS ERYTHEMATOSUS BY DRUGS, ARCHIVES OF INTERNAL MEDICINE 117: 620 (1966).","journal-title":"ARCHIVES OF INTERNAL MEDICINE"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0076-6879(67)12135-6","volume":"12","year":"1968","unstructured":"Shapiro, H, Methods in Enzymology 12A: 212 (1968).","journal-title":"Methods in Enzymology"},{"key":"e_1_2_1_16_1","first-page":"1","year":"1973","unstructured":"Stollar, B. D., The Antigens: 1 (1973).","journal-title":"The Antigens"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/cpt1977216715","volume":"21","year":"1977","unstructured":"TALSETH, T, KINETICS OF HYDRALAZINE ELIMINATION, CLINICAL PHARMACOLOGY & THERAPEUTICS 21: 715 (1977).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_18_1","first-page":"1078","volume":"2","year":"1978","unstructured":"Tan, E., Immunological Diseases 2: 1078 (1978).","journal-title":"Immunological Diseases"},{"key":"e_1_2_1_19_1","first-page":"1894","volume":"33","year":"1974","unstructured":"TAN, E.M., DRUG-INDUCED AUTOIMMUNE-DISEASE, FEDERATION PROCEEDINGS 33: 1894 (1974).","journal-title":"FEDERATION PROCEEDINGS"},{"key":"e_1_2_1_20_1","first-page":"3693","volume":"35","year":"1975","unstructured":"TOTH, B, SYNTHETIC AND NATURALLY OCCURRING HYDRAZINES AS POSSIBLE CANCER CAUSATIVE AGENTS, CANCER RESEARCH 35: 3693 (1975).","journal-title":"CANCER RESEARCH"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.7367866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:57:23Z","timestamp":1705294643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.7367866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,4,25]]},"references-count":20,"journal-issue":{"issue":"4442","published-print":{"date-parts":[[1980,4,25]]}},"alternative-id":["10.1126\/science.7367866"],"URL":"https:\/\/doi.org\/10.1126\/science.7367866","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,4,25]]}}}